Back to all papers

Morphological set enrichment enables interpretable prognostication and molecular profiling of meningiomas

February 24, 2026medrxiv logopreprint

Authors

Ayad, M. A.,McCortney, K.,Congivaram, H. T. S.,Hjerthen, M. G.,Steffens, A.,Zhang, H.,Youngblood, M. W.,Heimberger, A. B.,Chandler, J. P.,Jamshidi, P.,Ahrendsen, J. T.,Magill, S. T.,Raleigh, D. R.,Horbinski, C. M.,Cooper, L. A. D.

Affiliations (1)

  • Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA ; Chan Zuckerberg Biohub, Chicago, IL, USA

Abstract

Meningiomas are the most common primary brain tumors and, despite their benign reputation, often behave aggressively. Meningiomas are morphologically heterogeneous, yet the full significance of their histologic diversity is unclear. This is in large part because many features are not readily quantifiable by traditional observer-based light microscopy. Molecular testing improves prognostic stratification, but is not universally accessible. We therefore sought to determine whether an artificial intelligence (AI)-trained program could predict specific genomic and epigenomic patterns in meningiomas, and whether it could extract more prognostic information out of standard hematoxylin and eosin (H&E) histopathology than the current WHO classification. To do this, we developed Morphologic Set Enrichment (MSE), an interpretable computational pathology framework that quantifies statistical enrichment of morphologic patterns, cells, and tissue architecture from H&E whole-slide images. The MSE meningioma histology program was able to accurately predict DNA methylation subtypes and concurrent chromosome 1p/22q losses, in the process identifying specific morphologic patterns associated with key genomic and epigenomic alterations. It also added prognostic value independent of standard clinical and pathological variables. These results demonstrate that AI-based quantitative morphologic profiling can capture clinically and biologically relevant information that redefines risk stratification for meningiomas, incorporating histological information not included in existing grading schemes.

Topics

pathology

Ready to Sharpen Your Edge?

Subscribe to join 11k+ peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.